Lexaria Bioscience Corp. Common Stock (LEXX) is a publicly traded Healthcare sector company. As of May 19, 2026, LEXX trades at $0.57 with a market cap of $14.68M and a P/E ratio of 0.00. LEXX moved -0.07% today. Year to date, LEXX is -14.36%; over the trailing twelve months it is -44.54%. Its 52-week range spans $0.46 to $3.39. Rallies surfaces LEXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LEXX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LEXX recently traded at $0.57. Market cap is $14.68M. P/E ratio is 0.00. Revenue is $705.92K.
| Metric | Value |
|---|---|
| Price | $0.57 |
| Market Cap | $14.68M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.39 |
| 52-Week Low | $0.46 |
| Volume | 38.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $705.92K |
| Net Income | $-11.91M |
| Gross Margin | 99.61% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $705.92K | $-11.91M | $0.00 |
| 2024 | $464.28K | $-5.81M | $0.00 |
| 2023 | $226.21K | $-6.71M | $0.00 |
| 2022 | $255.40K | $7.38M | $0.00 |
LEXX analyst coverage data. Average price target: $0.00.